|
Market Closed -
Euronext Paris
09:25:00 28/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.340 EUR | -0.85% |
|
-5.65% | -13.65% |
| 23/09 | GenOway teams up with Taconic Biosciences to accelerate in the United States | |
| 23/09 | GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: genOway
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 21.45 | 37.85 | 35.3 | 40.59 | 34.58 | 24.99 |
| Change | - | 76.49% | -6.76% | 15% | -14.82% | -27.73% |
| Enterprise Value (EV) 1 | 29.49 | 43.07 | 39.45 | 43.56 | 35.2 | 31.7 |
| Change | - | 46.05% | -8.41% | 10.42% | -19.2% | -9.93% |
| P/E | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - |
| Capitalization / Revenue | 1.32x | 1.93x | 1.67x | 1.62x | 1.34x | 0.96x |
| EV / Revenue | 1.81x | 2.2x | 1.87x | 1.74x | 1.36x | 1.22x |
| EV / EBITDA | 34.9x | 99.8x | 13.1x | 7.49x | 9.04x | 7.16x |
| EV / EBIT | -78.2x | -54.6x | 80.7x | 27.8x | 27x | 24.9x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 16.29 | 19.59 | 21.09 | 25.02 | 25.84 | 26.03 |
| EBITDA 1 | 0.844 | 0.4318 | 3.006 | 5.815 | 3.894 | 4.428 |
| EBIT 1 | -0.3771 | -0.7893 | 0.4886 | 1.565 | 1.304 | 1.274 |
| Net income 1 | -0.6873 | -0.3226 | 0.7778 | 1.568 | 1.831 | 0.9278 |
| Net Debt 1 | 8.045 | 5.22 | 4.156 | 2.973 | 0.623 | 6.718 |
| Reference price 2 | 3.100 | 4.290 | 4.000 | 4.600 | 3.750 | 2.710 |
| Nbr of stocks (in thousands) | 6,919 | 8,824 | 8,824 | 8,824 | 9,220 | 9,220 |
| Announcement Date | 28/04/22 | 28/04/22 | 28/04/23 | 01/05/24 | 29/04/25 | 30/04/26 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 2.48Cr | ||
| 33.26x | 5.97x | 17.88x | 0.98% | 4.8TCr | ||
| 34.82x | 3.35x | 14.46x | -.--% | 4.45TCr | ||
| -21.07x | 227.64x | -22.77x | -.--% | 4.39TCr | ||
| 47.27x | 5.47x | 29.96x | -.--% | 4.1TCr | ||
| 26.85x | 7.74x | 19.93x | 0.42% | 2.99TCr | ||
| 35.19x | 5.78x | 26.24x | -.--% | 1.73TCr | ||
| -61.04x | 9.99x | 243.78x | -.--% | 1.53TCr | ||
| 25.79x | 2.21x | 9.6x | 1.04% | 1.53TCr | ||
| Average | 15.13x | 33.52x | 42.38x | 0.3% | 2.84TCr | |
| Weighted average by Cap. | 19.70x | 43.80x | 26.11x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALGEN Stock
- Valuation genOway
Select your edition
All financial news and data tailored to specific country editions
















